Volanesorsen Sodium News
Volanesorsen Sodium currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Volanesorsen Sodium with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Waylivra is indicated as an adjunct to diet in adult patients with genetically confirmed familial chylomicronemia syndrome (FCS) and at high risk for pancreatitis, in whom response to diet and...
- Evidence level: L5
- Predicted indications (20):
- megaloblastic anemia (disease) (100.0%)
- sclerosing cholangitis (100.0%)
- sickle cell disease and related diseases (100.0%)
- hereditary persistence of fetal hemoglobin-sickle cell disease syndrome (100.0%)
- sickle cell-hemoglobin d disease syndrome (100.0%)
- sickle cell-hemoglobin c disease syndrome (100.0%)
- sickle cell-hemoglobin E disease syndrome (100.0%)
- sickle cell-beta-thalassemia disease syndrome (100.0%)
- meningococcal infection (100.0%)
- paroxysmal nocturnal hemoglobinuria (100.0%)
- IgG4-related pachymeningitis (100.0%)
- IgG4-related retroperitoneal fibrosis (100.0%)
- mixed-type autoimmune hemolytic anemia (100.0%)
- non-infectious meningitis (100.0%)
- drug-induced autoimmune hemolytic anemia (100.0%)
- autosomal recessive severe congenital neutropenia due to G6PC3 deficiency (100.0%)
- infectious meningitis (100.0%)
- bone Paget disease (100.0%)
- psoriasis (100.0%)
- proteinuria (100.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.